NAPLES, Fla., Jan. 6, 2022 /CNW/ – Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a patient-centric biotechnology company developing next-generation mental health and oncology treatments by leveraging psychedelic-derived molecules for the mind and…
Read More
NAPLES, Fla., Dec. 6, 2021 — Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a patient-centric biotechnology company developing next-generation mental health and oncology treatments by leveraging psychedelic-derived molecules for the mind and synthetic…
Read More
– Significant Reduction in Dermatitis Severity Demonstrated NAPLES, Fla., Nov. 18, 2021 /CNW/ – Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a patient-centric biotechnology company developing next-generation mental health and cancer support care…
Read More
NAPLES, Fla., Nov. 8, 2021 /CNW/ – Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a patient-centric biotechnology company developing next-generation mental health and oncology treatments by leveraging psychedelic-derived molecules for the mind…
Read More
NAPLES, Fla., Oct. 26, 2021 — Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a patient-centric biotechnology company developing next-generation mental health and oncology treatments by leveraging psychedelic-derived molecules for the mind and synthetic…
Read More
NAPLES, Fla., Oct. 7, 2021 — Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a patient-centric biotechnology company developing next-generation mental health and oncology treatments by leveraging psychedelic-derived molecules for the mind and…
Read More
– Paving the way to select lead drug candidates for preclinical studies to support clinical evaluation in cancer-related distress – NAPLES, Fla., Oct. 5, 2021 — Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”),…
Read More
NAPLES, Fla., Sept. 20, 2021 — Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company developing a next-generation mental health and oncology treatment clinical discovery platform for the mind and body…
Read More
Enveric intends to immediately accelerate the development of a novel Psychedelic molecule for Cancer Related Distress NAPLES, Fla., Sept. 17, 2021 — Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a patient-centric biotechnology…
Read More
NAPLES, Fla., Sept. 9, 2021 — Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a patient-first biotechnology company developing novel cannabinoid medicines to improve quality of life for cancer patients, today announced that…
Read More
